World6 hours ago
Real-World Data Confirm Ibrutinib’s Role in Relapsed CLL
Results of a large real-world cohort study including more than 3300 patients confirm that ibrutinib is an effective salvage treatment for relapsed/refractory chronic lymphocytic leukemia (R/R...
